New non-invasive approach to cancer treatment shows promise

29 June 2016

A new non-invasive approach to killing cancer cells has shown promise as a potential means of treating inoperable or hard-to-reach tumours.

Research carried out by the University of Texas at San Antonio has demonstrated the benefits of a technique that involves injecting a chemical compound called nitrobenzaldehyde into the tumour, which then diffuses into the tissue.

A beam of light is then aimed at the tissue, causing the cells to become very acidic inside and eventually perish. Within two hours, it is estimated that up to 95 per cent of the targeted cancer cells can be killed.

The team tested this method on mice with triple-negative breast cancer, one of the most aggressive types of cancer and one of the hardest to treat. After one round of treatment in the laboratory, tumour growth was halted, thereby doubling the chances of survival.

Matthew Gdovin, an associate professor in the University of Texas at San Antonio's department of biology, said: "There are so many types of cancer for which the prognosis is very poor. We're thinking outside the box and finding a way to do what for many people is simply impossible."

Posted by Philip Briggs


Health News is provided by Axonn Media in collaboration with Spire Healthcare. Please note that all copy above is ©Axonn Media and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)